TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

SABA ILAC SANAYIVE

Pharmaceuticals
Generics

SABA ILAC SANAYIVE is a generic drug manufacturer with 1 FDA-approved products.

2024
Since
1
Drugs
-
Trials
12
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

FUROSEMIDE 2026-01-08
FUROSEMIDE 2025-09-12
Labeling
FUROSEMIDE 2025-09-08
Labeling
FUROSEMIDE 2025-08-06
Labeling
FUROSEMIDE 2025-07-17
FUROSEMIDE 2025-05-08
Labeling
FUROSEMIDE 2024-12-13
FUROSEMIDE 2024-10-01
Labeling
FUROSEMIDE 2024-10-01
Labeling
FUROSEMIDE 2024-10-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

No indication data

Pipeline Strength Pro

Loading...